tislelizUMaB in canceR Patients With molEcuLar residuaL Disease

Clinical trial NCT06332274 · RECRUITING

Trial details

NCT number: NCT06332274
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cancer Lung Cancer Colo-rectal Cancer Pancreas Cancer Soft Tissue Sarcoma

Start date: 2025-04-16
Primary completion: 2029-04-01
Enrollment: 717

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.